Dosage and cost: Sildenafil is available through Hims by prescription in 25-, 50-, or 100-milligram (mg) pills, starting at $4 per dose. Brand-name Viagra is also available through Hims in 25-, 50 ...

We include products we think are useful for our readers. If you buy through links on this page, we may earn a small commission or other tangible benefit. Optum Store, Optum Perks, and Healthline ...

and the only cost attributed is the cost for the specific medication prescribed or supplements chosen,” according to a Hims customer service representative. The process for obtaining a ...

Price – The cost per dose of Hims Hard ... the active ingredient in Viagra, unfortunately Hims hard mints no longer contain ...

But Hims & Hers Health Inc. — the online telehealth platform best known for selling hair-loss treatments, Viagra and Cialis ... platform at an affordable price continues to resonate with ...

Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Monday. The company is set to join to the S&P SmallCap 600 this ...

Hims is also a telehealth company that offers ... much more affordable than branded options. For instance, Viagra can cost around $90 per pill, whereas its generic, sildenafil, can cost around ...

The ad is for Hims, a men's health startup know for selling generic Viagra and hair-loss medications. It's an approach that's getting a lot of attention as investors are wagering that consumers ...

SG Americas Securities LLC trimmed its stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Free Report) by 34.1% in the ...

The FDA has resolved Eli Lilly's tirzepatide shortage, but localized supply issues persist. Meanwhile, Hims & Hers Health's ...

Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $17.66 which represents a slight increase of $0.53 or 3.09% from the prior close of $17.13. The stock opened at $17.55 and ...

Telehealth company Hims & Hers Health (HIMS 3.09%) has been great for investors this year by almost any standard; share prices have nearly doubled from a year ago. Yet shareholders aren't feeling ...